Disseminated cytomegalovirus disease after bendamustine: a case report and analysis of circulating B- and T-cell subsets

BACKGROUND: Bendamustine, used for the treatment of indolent B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia, is known to cause prolonged myelosuppression and lymphocytopenia and has been associated with the risk of developing serious and fatal infections. While reports of localized CMV...

Descripción completa

Detalles Bibliográficos
Autores principales: Cona, Andrea, Tesoro, Daniele, Chiamenti, Margherita, Merlini, Esther, Ferrari, Daris, Marti, Antonio, Codecà, Carla, Ancona, Giuseppe, Tincati, Camilla, d’Arminio Monforte, Antonella, Marchetti, Giulia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806551/
https://www.ncbi.nlm.nih.gov/pubmed/31640581
http://dx.doi.org/10.1186/s12879-019-4545-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6806551/
https://www.ncbi.nlm.nih.gov/pubmed/31640581
http://dx.doi.org/10.1186/s12879-019-4545-7

Ejemplares similares